Valion Bio, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company was founded by Jennifer Ernst and John Claude on September 22, 2016 and is headquartered in San Antonio, TX.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
52
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Valion Bio Inc. market cap is $2.51M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Valion Bio Inc. 52 week high is $78.75 as of November 20, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Valion Bio Inc. 52 week low is $2.05 as of November 20, 2026.
Valion Bio Inc. stock price today is $2.79.
Valion Bio Inc. stock price yesterday was $2.83.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Valion Bio Inc.'s P/E ratio is -0.01.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Valion Bio Inc. P/B ratio is 0.1107.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Valion Bio Inc. 50-day moving average is $4.47.